Cannabis company Tilray Brands has become the center of Wall Street attention as shares rocketed 17.52% following reports that President Trump is considering reclassifying marijuana from its current Schedule I status to the less restrictive Schedule III category. The potential policy shift has ignited investor enthusiasm across the entire cannabis sector, with Tilray emerging as […]

The postTilray stock soars 17% amid Trump cannabis reform buzzappeared first onRolling Out.